Novo Nordisk NVO enjoys a robust presence in the Diabetes care market, with a global value market share of 27%. The company has a leading presence in the total insulin market, and modern and new-generation insulin market, with a …
Novo Nordisk NVO is a global healthcare company and a leader in the worldwide diabetes market. Also, the company is a key player in hemophilia care, growth hormone therapy, hormone replacement therapy and obesity. However, let’s find …
Focus this week was on the 36th annual JPMorgan healthcare conference where several biotech and pharma companies …